Onilcamotide
Product Specifications
CAS Number
1164096-85-8
Bioactivity
Onilcamotide, a cancer vaccine derived from the C-terminal peptide of the RhoC protein, exhibits potential immunomodulating and antineoplastic activities.
Smiles
CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O
Molecular Formula
C96H177N39O24S
Molecular Weight
2293.78
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
208705-01 2 µg
Transforming Growth Factor beta1, Recombinant, Human, Animal Free (TGF-beta1, Differentiation Inhibiting Factor, Cartilage-Inducing Factor)
Sign In for Pricing
View Details 208705-02 10 µg
Transforming Growth Factor beta1, Recombinant, Human, Animal Free (TGF-beta1, Differentiation Inhibiting Factor, Cartilage-Inducing Factor)
Sign In for Pricing
View Details 
I7663-24B-ML490 100 µL
Interleukin 1 beta (IL1b, IL-1 beta, Catabolin, Hematopoietin 1, H1, IFN beta Inducing Factor, IL1F2, LAF, OAF, Osteoclast Activating Factor, Preinterleukin beta, Pro Interleukin 1 beta) (MaxLight 490)
Sign In for Pricing
View Details